241 related articles for article (PubMed ID: 34622662)
1. Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension.
Daly CM; Griffiths M; Simpson CE; Yang J; Damico RL; Vaidya RD; Williams M; Brandal S; Jone PN; Polsen C; Ivy DD; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Nies MK; Rosenzweig EB; Hirsch R; Yung D; Everett AD
J Am Heart Assoc; 2021 Oct; 10(20):e021409. PubMed ID: 34622662
[TBL] [Abstract][Full Text] [Related]
2. Lung Function, Inflammation, and Endothelin-1 in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.
Low A; George S; Howard L; Bell N; Millar A; Tulloh RMR
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29444773
[TBL] [Abstract][Full Text] [Related]
3. Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
Li G; Li Y; Tan XQ; Jia P; Zhao J; Liu D; Wang T; Liu B
Pediatr Cardiol; 2017 Dec; 38(8):1620-1626. PubMed ID: 28819713
[TBL] [Abstract][Full Text] [Related]
4. Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. a systematic review.
Giannakoulas G; Mouratoglou SA; Gatzoulis MA; Karvounis H
Int J Cardiol; 2014 Jul; 174(3):618-23. PubMed ID: 24814894
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential serum biomarkers for congenital heart disease children with pulmonary arterial hypertension by metabonomics.
Jin N; Yu M; Du X; Wu Z; Zhai C; Pan H; Gu J; Xie B
BMC Cardiovasc Disord; 2023 Mar; 23(1):167. PubMed ID: 36991345
[TBL] [Abstract][Full Text] [Related]
6. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
7. Plasma Connective Tissue Growth Factor as a Biomarker of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Adults.
Liu W; Hua Y; Zheng D; Lv W; Zhang W; Chen Q; Huang R; Li X
Circ J; 2023 Mar; 87(4):527-535. PubMed ID: 36843115
[TBL] [Abstract][Full Text] [Related]
8. Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry.
Hill KD; Lim DS; Everett AD; Ivy DD; Moore JD
Catheter Cardiovasc Interv; 2010 Nov; 76(6):865-73. PubMed ID: 20549685
[TBL] [Abstract][Full Text] [Related]
9. Plasma copeptin levels in children with pulmonary arterial hypertension associated with congenital heart disease.
Gaheen R; El Amrousy D; Hodeib H; Elnemr S
Eur J Pediatr; 2021 Sep; 180(9):2889-2895. PubMed ID: 33813676
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Long-Term Oral Bosentan in Different Types of Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
Kuang HY; Li Q; Du HA; Chen M; Yin YH
Am J Cardiovasc Drugs; 2021 Mar; 21(2):181-191. PubMed ID: 32918210
[TBL] [Abstract][Full Text] [Related]
11. Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.
Damico R; Kolb TM; Valera L; Wang L; Housten T; Tedford RJ; Kass DA; Rafaels N; Gao L; Barnes KC; Benza RL; Rand JL; Hamid R; Loyd JE; Robbins IM; Hemnes AR; Chung WK; Austin ED; Drummond MB; Mathai SC; Hassoun PM
Am J Respir Crit Care Med; 2015 Jan; 191(2):208-18. PubMed ID: 25489667
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Pulmonary Artery Compliance in Patients with Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease.
Cheng XL; Liu ZH; Gu Q; Ni XH; Luo Q; Zhao ZH; He JG; Xiong CM
Int Heart J; 2017 Oct; 58(5):731-738. PubMed ID: 28966315
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
[TBL] [Abstract][Full Text] [Related]
14. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.
Ploegstra MJ; Roofthooft MT; Douwes JM; Bartelds B; Elzenga NJ; van de Weerd D; Hillege HL; Berger RM
Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552488
[TBL] [Abstract][Full Text] [Related]
15. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
[TBL] [Abstract][Full Text] [Related]
16. ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical Worsening.
Griffiths M; Yang J; Simpson CE; Vaidya D; Nies M; Brandal S; Damico R; Ivy DD; Austin ED; Pauciulo MW; Lutz KA; Rosenzweig EB; Hirsch R; Yung D; Nichols WC; Everett AD
Chest; 2021 Jul; 160(1):297-306. PubMed ID: 33609516
[TBL] [Abstract][Full Text] [Related]
17. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
[TBL] [Abstract][Full Text] [Related]
18. Platelet activation markers in children with congenital heart disease associated with pulmonary arterial hypertension.
Mese T; Guven B; Yilmazer MM; Karadeniz C; Ozdemir R; Doksoz O
Congenit Heart Dis; 2018 Jul; 13(4):506-511. PubMed ID: 30019380
[TBL] [Abstract][Full Text] [Related]
19. Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease.
Luna-Lopez R; Segura de la Cal T; Sarnago Cebada F; Martin de Miguel I; Hinojosa W; Cruz-Utrilla A; Velazquez MT; Delgado JF; Mendoza A; Arribas Ynsaurriaga F; Escribano-Subías P
Heart; 2024 Feb; 110(5):346-352. PubMed ID: 37903556
[TBL] [Abstract][Full Text] [Related]
20. Congenital heart disease with pulmonary artery hypertension in an Asian cohort-initial report from TACHYON (TAiwan congenital heart disease associated with pulmonarY arterial hypertension) registry.
Chiu SN; Weng KP; Lin MC; Wang JN; Hwang BT; Dai ZK; Lin SM; Chang JS; Lin IC; Wu MH; Lu CW; Lin MT; Chen CA; Hua YC; Wu JM; Wang JK;
Int J Cardiol; 2020 Oct; 317():49-55. PubMed ID: 32522677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
